Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium

The document discusses Telogen Effluvium (TE), a type of hair loss experienced by approximately 25% of COVID-19 patients, particularly women, within two to three months after infection. This condition is triggered by the viral infection and pandemic-related stressors. The paper suggests various strategies to reduce post-COVID-19 hair loss and promote hair regrowth, including patient education, stress-coping mechanisms, dietary interventions, oral hair growth supplements, and local treatments like topical therapy with minoxidil and minimally invasive scalp injections. The decision to initiate any of these treatments should be made on a case-by-case basis, considering all psychosocial and physiological factors and patient preferences. The document emphasizes that hair loss after COVID-19 is usually temporary, with improvement expected after 6 to 12 months. Optimal nutrition, including a diet rich in vitamins and minerals, is crucial to mitigate hair loss. Oral micronutrient supplementation can alleviate the severity of hair loss and support regrowth, particularly in individuals with detected deficiencies. The document also discusses the use of oral supplements like Vitamin D, Vitamin E, Biotin, Zinc, and Iron, as well as marine-derived nutraceuticals. Topical Minoxidil, a vasodilator that promotes hair growth, is recommended, along with plant-derived stimulators like rosemary oil. Other treatments like mesotherapy, botulinum toxin injections, and Platelet-Rich Plasma (PRP) therapy are also discussed. The document concludes that a holistic approach integrating these measures is the most effective strategy for hair regrowth after post-COVID-19 TE.